Development and optimization of stealth liposomal system for enhanced in vitro cytotoxic effect of quercetin
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Drug Delivery Science and Technology"
DOI: 10.1016/j.jddst.2019.101477
Abstract: Abstract The present study was designed to develop a stealth liposomal drug delivery system for a naturally occurring flavonoid, quercetin. Quercetin is a unique polyphenol with multifarious curative applications, anticancer activity being one of them.… read more here.
Keywords: stealth liposomal; liposomal system; stealth; solubility ... See more keywords
Assisting anti-PD-1 antibody treatment with a liposomal system capable of recruiting immune cells.
Sign Up to like & getrecommendations! Published in 2019 at "Nanoscale"
DOI: 10.1039/c9nr01434a
Abstract: Despite the functions of anti-PD-1 antibodies as immune checkpoint regulators, less than 30% of patients exhibit durable therapeutic responses to anti-PD-1 antibodies. Studies have shown that insufficient infiltration of immune cells might limit the outcome… read more here.
Keywords: assisting anti; anti antibody; treatment; liposomal system ... See more keywords
Design of Novel Tricaprylin-Incorporated Multi-Layered Liposomal System for Skin Delivery of Ascorbic Acid with Improved Chemical Stability
Sign Up to like & getrecommendations! Published in 2023 at "Pharmaceuticals"
DOI: 10.3390/ph16010121
Abstract: L-ascorbic acid (Vit C) possesses a variety of dermatological functions in maintaining skin health and anti-aging properties. However, its topical application is challenging owing to its liability to light, oxygen, or heat. Therefore, in this… read more here.
Keywords: system; chemical stability; liposomal system; ascorbic acid ... See more keywords
Formulation, Development, and In Vitro Evaluation of a CD22 Targeted Liposomal System Containing a Non-Cardiotoxic Anthracycline for B Cell Malignancies
Sign Up to like & getrecommendations! Published in 2018 at "Pharmaceutics"
DOI: 10.3390/pharmaceutics10020050
Abstract: Doxorubicin cardiotoxicity has led to the development of superior chemotherapeutic agents such as AD 198. However, depletion of healthy neutrophils and thrombocytes from AD 198 therapy must be limited. This can be done by the… read more here.
Keywords: system; development vitro; liposomal system; cd22 targeted ... See more keywords